Gesynta Pharma
Gesynta Pharma is a biotech company in Stockholm, Sweden.
- Headquarters
- Stockholm
- Website
- gesynta.se
About
Gesynta Pharma develops drug candidates intended to reduce harmful inflammation and pain, drawing on research originating from Karolinska Institutet. Its lead candidate, vipoglanstat, inhibits the inflammation-related enzyme mPGES-1 and is being evaluated in patients with endometriosis. Its pipeline also includes drug candidates with anti-inflammatory and pain-relieving properties.
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/gesynta-pharma"><img src="https://indexed.vc/api/badge/company/gesynta-pharma" alt="Gesynta Pharma on Indexed.vc" width="260" height="76" /></a>